Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017

Kasia Trzcionkowska, Wouter B. H. J. Vehmeijer, Frank T. Kerkhoff, Noel J. C. Bauer, Carlien A. M. Bennebroek, Peter H. Dijk, Koen P. Dijkman, Frank A. M. van den Dungen, Cathrien A. Eggink, Robert P. G. Feenstra, Floris Groenendaal, Arno F. van Heijst, Mark A. H. B. M. van der Hoeven, Rene F. Kornelisse, Elke Kraal-Biezen, Enrico Lopriore, Wes Onland, Victor W. Renardel de Lavalette, Laurentius J. van Rijn, Frank A. B. A. SchuermanHuibert J. Simonsz, Elsbeth S. M. Voskuil-Kerkhof, Ruben S. G. M. Witlox, Jacqueline U. M. Termote, Nicoline E. Schalij-Delfos*

*Bijbehorende auteur voor dit werk

    OnderzoeksoutputAcademicpeer review

    2 Citaten (Scopus)
    13 Downloads (Pure)

    Samenvatting

    Purpose Compare patients treated for Retinopathy of Prematurity (ROP) in two consecutive periods. Methods Retrospective inventory of anonymized neonatal and ophthalmological data of all patients treated for ROP from 2010 to 2017 in the Netherlands, subdivided in period (P)1: 1-1-2010 to 31-3-2013 and P2: 1-4-2013 to 31-12-2016. Treatment characteristics, adherence to early treatment for ROP (ETROP) criteria, outcome of treatment and changes in neonatal parameters and policy of care were compared. Results Overall 196 infants were included, 57 infants (113 eyes) in P1 and 139 (275 eyes) in P2, indicating a 2.1-fold increase in ROP treatment. No differences were found in mean gestational age (GA) (25.9 +/- 1.7 versus 26.0 +/- 1.7 weeks, p = 0.711), mean birth weight (791 +/- 311 versus 764 +/- 204 grams, p = 0.967) and other neonatal risk factors for ROP. In P2, the number of premature infants born

    Originele taal-2English
    Pagina's (van-tot)97-103
    Aantal pagina's7
    TijdschriftActa ophthalmologica
    Volume99
    Nummer van het tijdschrift1
    Vroegere onlinedatum23-jul-2020
    DOI's
    StatusPublished - feb-2021

    Citeer dit